Rapid Dose Therapeutics Statistics

Total Valuation

CSE:DOSE has a market cap or net worth of CAD 27.70 million. The enterprise value is 30.27 million.

Market Cap	27.70M
Enterprise Value	30.27M

Important Dates

The last earnings date was Friday, June 27, 2025.

Earnings Date	Jun 27, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:DOSE has 131.89 million shares outstanding. The number of shares has increased by 18.68% in one year.

Current Share Class	131.89M
Shares Outstanding	131.89M
Shares Change (YoY)	+18.68%
Shares Change (QoQ)	+1.27%
Owned by Insiders (%)	10.26%
Owned by Institutions (%)	n/a
Float	118.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.28
PB Ratio	-5.32
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.60
EV / Sales	18.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-26.26

Financial Position

The company has a current ratio of 0.10

Current Ratio	0.10
Quick Ratio	0.05
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.26
Interest Coverage	-3.39

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-148.14%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	80.14%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.18
Inventory Turnover	4.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.51% in the last 52 weeks. The beta is -0.21, so CSE:DOSE's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	+13.51%
50-Day Moving Average	0.20
200-Day Moving Average	0.21
Relative Strength Index (RSI)	51.12
Average Volume (20 Days)	44,087

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:DOSE had revenue of CAD 2.09 million and -5.40 million in losses. Loss per share was -0.04.

Revenue	2.09M
Gross Profit	1.18M
Operating Income	-4.17M
Pretax Income	-5.40M
Net Income	-5.40M
EBITDA	-3.93M
EBIT	-4.17M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 20,717 in cash and 2.61 million in debt, giving a net cash position of -2.59 million or -0.02 per share.

Cash & Cash Equivalents	20,717
Total Debt	2.61M
Net Cash	-2.59M
Net Cash Per Share	-0.02
Equity (Book Value)	-5.21M
Book Value Per Share	-0.04
Working Capital	-6.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.15 million and capital expenditures -5,740, giving a free cash flow of -1.15 million.

Operating Cash Flow	-1.15M
Capital Expenditures	-5,740
Free Cash Flow	-1.15M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 56.59%, with operating and profit margins of -200.07% and -259.18%.

Gross Margin	56.59%
Operating Margin	-200.07%
Pretax Margin	-259.18%
Profit Margin	-259.18%
EBITDA Margin	-188.53%
EBIT Margin	-200.07%
FCF Margin	n/a

Dividends & Yields

CSE:DOSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.68%
Shareholder Yield	n/a
Earnings Yield	-19.51%
FCF Yield	-4.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2